When comparing the 25 stool and inflammatory markers, including IL-2, IL-4, tumor necrosis factor, and interferon, there were no statistically significant differences between the ALS patients and the healthy controls. This evidence concerns the gene TNF and amyotrophic lateral sclerosis.